Walleye Capital LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$4,658,993
+129.0%
29,300
+103.7%
0.01%
+50.0%
Q2 2023$2,034,478
+368.8%
14,382
+523.9%
0.01%
-33.3%
Q1 2022$434,000
+6.1%
2,305
+63.0%
0.01%0.0%
Q3 2021$409,000
+92.9%
1,414
+33.4%
0.01%
+71.4%
Q2 2021$212,000
-15.5%
1,060
-19.1%
0.01%
-58.8%
Q4 2020$251,000
-50.7%
1,311
-76.2%
0.02%
-48.5%
Q4 2019$509,000
-80.6%
5,500
-83.9%
0.03%
-78.8%
Q3 2019$2,621,000
-57.3%
34,164
-52.1%
0.16%
-76.9%
Q2 2019$6,134,000
+1548.9%
71,360
+1032.7%
0.68%
+1006.6%
Q1 2019$372,0006,3000.06%
Other shareholders
REPLIGEN CORP shareholders Q3 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders